According to Blueprint Medicines 's latest financial reports the company's total debt is $0.33 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $0.33 B | 37.14% |
2022-12-31 | $0.24 B | 117.62% |
2021-12-31 | $0.11 B | 24.33% |
2020-12-31 | $89.6 M | -6.61% |
2019-12-31 | $95.94 M | 556.42% |
2018-12-31 | $14.61 M | -18.11% |
2017-12-31 | $17.84 M | 139.94% |
2016-12-31 | $7.43 M | -34.09% |
2015-12-31 | $11.28 M | 24.82% |
2014-12-31 | $9.04 M | 215.82% |
2013-12-31 | $2.86 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Pacific Biosciences
PACB | $0.93 B | 180.88% | ๐บ๐ธ USA |
OPKO Health
OPK | $0.32 B | -1.78% | ๐บ๐ธ USA |
Acceleron Pharma XLRN | N/A | N/A | ๐บ๐ธ USA |
Isoray
ISR | $0.39 M | -99.88% | ๐บ๐ธ USA |